Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Other Non-Current Assets (2020 - 2025)

Pulse Biosciences has reported Other Non-Current Assets over the past 6 years, most recently at $705000.0 for Q3 2025.

  • Quarterly results put Other Non-Current Assets at $705000.0 for Q3 2025, up 9.13% from a year ago — trailing twelve months through Sep 2025 was $705000.0 (up 9.13% YoY), and the annual figure for FY2024 was $677000.0, up 85.48%.
  • Other Non-Current Assets for Q3 2025 was $705000.0 at Pulse Biosciences, up from $677000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PLSE hit a ceiling of $714000.0 in Q2 2024 and a floor of $365000.0 in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $365000.0 (2021), compared with a mean of $465368.4.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 35.05% in 2021 and later soared 95.62% in 2024.
  • Pulse Biosciences' Other Non-Current Assets stood at $365000.0 in 2021, then changed by 0.0% to $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then soared by 85.48% to $677000.0 in 2024, then grew by 4.14% to $705000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $705000.0 (Q3 2025), $677000.0 (Q2 2025), and $678000.0 (Q1 2025) per Business Quant data.